C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) C07D 471/04 (2006.01) C07D 473/34 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2250241
Corticotropin releasing factor (CRF) antagonists of formula (I) or formula (II): and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
Cette invention concerne des antagonistes du facteur libérant de la corticotropine représentés par la formule (I) ou la formule (II), ainsi que leur utilisation dans le traitement de l'anxiété, de la dépression et d'autres troubles psychiatriques et neurologiques.
Arvanitis Argyrios Georgios
Bakthavatchalam Rajagopal
Beck James Peter
Cain Gary Avonn
Chorvat Robert John
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Du Pont Pharmaceuticals Company
LandOfFree
Arylamino fused pyridines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylamino fused pyridines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylamino fused pyridines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1684961